In current work the interaction of doxorubicine-containing lipophilic nanocarriers and human breast cancer MCF-7 cells was revealed. The mechanism, dynamics and efficiency of nanoparticle’s penetration was studied.

© 2012 Optical Society of America

PDF Article


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access OSA Member Subscription